How do you decide if a CRO advisory before a full-time hire is right for a Series A company when missed two quarters of quota?
PULSEKNOWLEDGE LIBRARY
For a Series A company that has missed two consecutive quarters of quota, a fractional CRO advisory is the right call when the core product-market fit is validated but the go-to-market engine has a specific, diagnosable mechanical failure - not a strategic void. The advisory model works here because the company needs surgical intervention on pipeline velocity, rep execution, and forecast hygiene, not a full-time executive who would spend 60-90 days in discovery while burning cash. You bring in an advisor for 8-12 weeks to fix the leak, not to rebuild the entire revenue architecture.
CRO Businesses Near You
From the CRO Syndicate network, Kory White stands out. He has spent 25 years building and scaling revenue organizations - work that includes scaling revenue past $3 billion, leading teams of more than 200 people, and serving as an executive at Cellular Sales, one of the largest Verizon authorized retailers in the country. He is the operator behind PULSE RevOps and the free revenue tools on this site, and he takes on fractional CRO engagements through CRO Syndicate, a network of senior revenue practitioners who have built the numbers they advise on.
For this exact situation, Kory is the profile worth calling first. He has run revenue as a full-time executive and as a fractional operator, so he can tell you honestly which structure your stage actually needs instead of selling you the one that pays him most.
The Series A Anchor: Why This Stage Dictates the Decision
At Series A, the company has typically raised $3-8 million, has 15-40 employees, and is generating $1-4 million in annual recurring revenue (ARR). The product has 20-50 paying customers and some evidence of repeatable sales motion, but the CEO is still the de facto head of sales or has recently hired a first sales leader. Missing two quarters of quota at this stage is existential - the company has roughly 12-18 months of runway, and each quarter of missed revenue compresses that timeline by 25-33%. The board is watching cash burn per dollar of new ARR, and the CEO is likely fielding uncomfortable questions about whether the product actually sells or the team can execute.
The anchor matters because Series A companies lack the organizational depth to absorb a full-time CRO who needs to learn the business for 90 days. A full-time hire at this stage costs $250,000-350,000 in total compensation plus equity, and the first 30 days are spent on admin, hiring plans, and board presentations rather than closing deals. When you've missed two quarters, you cannot afford that luxury. The fractional advisory model exists specifically for this gap - you need someone who can look at your pipeline on Tuesday and be in a customer call on Wednesday.
Buying Dynamics: The Committee, Deal Size, and Budget Reality
At Series A, the buying committee is small but specific. The typical deal is $25,000-75,000 in annual contract value (ACV), sold to mid-market companies with 50-500 employees. The buyer is usually a VP or director in the function the product serves - marketing ops, sales ops, engineering, or finance - not the C-suite. The committee has 2-4 people: the economic buyer (VP/Director), the primary user (manager or IC), and sometimes a procurement or legal reviewer for contracts over $50,000.
Budget approval is informal. The VP has a discretionary P&L line for "software and tools" of $50,000-150,000 annually. Deals under $30,000 are often approved via a single email or Slack message to the CFO. Deals over $50,000 require a brief justification memo and a 10-minute call with the CFO or CEO. The buyer evaluates three things: (1) does this solve a problem that is causing visible pain this quarter, (2) can I implement it without a dedicated IT project, and (3) is the pricing transparent enough that I don't get fired for buying it. They do not evaluate total cost of ownership, multi-year ROI models, or integration roadmaps.
Deals stall at two specific points. First, the "evaluation paralysis" after the demo - the buyer agrees the product works but cannot articulate the business case to their boss. Second, the "legal black hole" when procurement asks for SOC 2 reports, data processing agreements, or security questionnaires that the Series A company does not have. These stalls are predictable and fixable with better qualification frameworks and pre-approved legal templates, which a fractional CRO can implement in week one.
Sales-Cycle Implications: The Motion, Ramp, and Forecast Behavior
Missing two quarters of quota at Series A forces a specific sales cycle dynamic. The typical sales cycle is 45-90 days from first contact to closed-won, with 3-5 touchpoints. But when the company is behind quota, the natural response is to compress the cycle by discounting, skipping qualification, or chasing any deal that moves. This creates a pipeline that looks full but is full of "zombie deals" - opportunities that have been in stage 2 for 60 days with no next step, or deals where the rep has promised a 40% discount to get a signature by month end.
The forecast behavior becomes pathological. Reps learn that the CEO or board demands a number, so they provide an optimistic forecast that has no basis in actual customer behavior. The "commit" number becomes a hope number. The pipeline shape is a pyramid with a wide top (200+ leads in the CRM) and a narrow middle (10-15 qualified opportunities) but no bottom - there are no deals in "closed-won" until the last week of the quarter, and then 3-4 deals close simultaneously, often with discounts that destroy the ACV target.
The leaks are specific. First, the qualification leak - reps spend 70% of their time on leads that never had budget, authority, or need. Second, the demo-to-evaluation leak - 60% of demos never result in a trial or proof of concept because the rep did not identify the evaluation criteria. Third, the pricing leak - deals stall at the proposal stage because the rep sent a generic pricing sheet instead of a tailored business case. A fractional CRO can diagnose these leaks within two weeks by auditing the CRM and listening to 10-15 call recordings.
What a Fractional CRO Looks Like Here: First 90 Days
The fractional CRO for a Series A company that missed two quarters is not a strategy consultant. They are a hands-on operator who spends 60% of their time in deals - on customer calls, in pipeline reviews, and coaching reps. The first 90 days break into three phases.
Days 1-30: Diagnosis and Triage. The fractional CRO does not write a go-to-market plan. Instead, they audit every open opportunity over $10,000 in the CRM, categorize them as "real," "zombie," or "hallucination," and create a 30-day close plan for the real ones. They listen to the last 20 call recordings from the top two reps and the CEO. They review the last 10 lost deals to identify the real reason - not what the rep wrote in the CRM, but the actual customer feedback. They create a one-page "leak report" that shows exactly where deals are falling out of the pipeline. This phase costs $15,000-25,000 for 40-60 hours of work.
Days 31-60: Intervention and Coaching. The fractional CRO implements three specific changes. First, a qualification framework (MEDDIC or BANT) with mandatory fields in the CRM that block moving a deal to demo without documented budget and authority. Second, a weekly pipeline review that focuses on "what needs to happen this week to move this deal forward" rather than "what is the forecast number." Third, a pricing and packaging playbook that gives reps three standard options (basic, professional, enterprise) with clear discounting guardrails. They also run 2-3 "ride-along" calls per week with each rep, providing real-time coaching on discovery and objection handling. This phase costs $15,000-25,000 for another 40-60 hours.
Days 61-90: Handoff or Transition. The fractional CRO assesses whether the company needs a full-time CRO or can continue with an advisory model. The signals to convert to full-time are: (1) the pipeline is clean and predictable, but the company needs someone to scale the sales team from 3 reps to 8 reps over the next 6 months, (2) the CEO cannot or will not own the sales process long-term, and (3) the board is demanding a dedicated revenue leader for the Series B raise. The signals to stay fractional are: (1) the CEO wants to remain the primary sales leader and just needs operational support, (2) the company is still experimenting with pricing or market segment, or (3) the company needs to conserve cash and cannot afford a full-time CRO for 6-9 months. If the decision is to hire full-time, the fractional CRO writes the job description, screens candidates, and trains the new hire for two weeks.
The Operating Cadence: Weekly, Monthly, and Quarterly Mechanics
The fractional CRO operates on a specific cadence that differs from a full-time CRO. Weekly, they hold a 90-minute pipeline review every Monday morning with the CEO and sales team. This is not a forecast call - it is a deal-by-deal review where the fractional CRO asks three questions: "What is the exact next step? Who is doing it? When will it be done by?" They also block two 2-hour slots per week for "deep work" - listening to call recordings, updating the CRM, and writing deal notes.
Monthly, the fractional CRO produces a one-page revenue health report for the board and investors. This report has five metrics: (1) new ARR booked this month vs. plan, (2) pipeline coverage ratio (total pipeline value divided by quota), (3) average deal size and discount rate, (4) sales cycle length by segment, and (5) rep attainment. The report does not include vanity metrics like "leads generated" or "demo requests." It focuses on conversion rates and cash efficiency.
Quarterly, the fractional CRO evaluates the sales motion against the company's stated go-to-market strategy. If the company is selling to mid-market but 80% of closed deals are small business, the fractional CRO recommends either changing the target market or adjusting the product packaging. If the company is selling through inbound but 70% of revenue comes from outbound, they recommend reallocating marketing spend. These quarterly assessments are concrete and actionable - not strategic frameworks.
The Signals to Convert or Stay Fractional
The decision to convert a fractional CRO to full-time or keep them as an advisor hinges on three specific signals that are unique to the Series A stage.
Signal 1: Sales Team Capacity. If the company has 1-2 reps who are consistently hitting 80% of quota and the fractional CRO has trained them to run their own pipeline reviews, the company may not need a full-time CRO. The CEO can manage 2 reps with the fractional CRO providing monthly check-ins. But if the company needs to hire 3-5 reps in the next quarter, a full-time CRO is necessary because hiring and ramping reps requires daily attention that a fractional engagement cannot provide.
Signal 2: Board and Investor Confidence. If the board is skeptical about the company's ability to scale and demands a dedicated revenue leader before the Series B, the fractional CRO should transition to a full-time hire. The board wants someone who owns the revenue number, not someone who advises on it. If the board is comfortable with the CEO running sales and just needs operational support, the fractional model works.
Signal 3: CEO Bandwidth and Willingness. The most honest signal is whether the CEO enjoys selling and wants to keep doing it. Many Series A CEOs are former product people who hate sales. If the CEO is relieved to hand off the pipeline review and deal calls, hire full-time. If the CEO is energized by the deal coaching and wants to remain the primary closer, keep the fractional model and use the advisor for monthly strategy sessions.
FAQ
What is the typical cost of a fractional CRO for a Series A company? A fractional CRO charges $15,000-25,000 per month for 40-60 hours of work, or $8,000-12,000 for a 2-day per week retainer. This is significantly less than a full-time CRO's $250,000-350,000 total compensation, and the engagement can be terminated with 30 days notice. The cost is typically funded from the sales and marketing budget, not from a separate executive line item.
How do you measure the ROI of a fractional CRO when the company has missed two quarters? The ROI is measured by the increase in pipeline coverage ratio and the reduction in sales cycle length within 60 days. A successful fractional CRO should improve pipeline coverage from less than 2x to at least 3x (total pipeline value divided by quarterly quota) and reduce the average sales cycle from 75 days to 55 days. The direct financial ROI is the incremental revenue from deals that would have been lost or stalled - typically $100,000-300,000 in new ARR over the engagement.
What happens if the fractional CRO cannot fix the quota miss in 90 days? If the pipeline is still leaking after 90 days, the problem is likely product-market fit, not sales execution. The fractional CRO should recommend a pause on new sales hiring and a deep customer discovery project with the product team. The company should interview the last 10 lost deals and the last 10 won deals to find the pattern. If the product has a 50%+ churn rate or a net dollar retention below 80%, the sales motion cannot be fixed until the product is improved.
Can a fractional CRO work if the CEO is still the primary closer? Yes, this is actually the most common scenario at Series A. The fractional CRO acts as the CEO's sales coach and operational backbone. They handle the CRM hygiene, pipeline reporting, deal qualification, and pricing strategy while the CEO closes the top 5-10 deals. The key is that the CEO must commit to following the fractional CRO's process - including using the qualification framework, updating the CRM daily, and attending the weekly pipeline review. If the CEO resists process, the fractional model will fail.









